Name
Berubicin
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
topoisomerase II inhibitor
NSC Number
None
Primary Site
Brain
Histology
Glioma
Remarks
June 12, 2020: Berubicin was granted Orphan Drug Designation by FDA for the treatment of malignant gliomas.
Coding
This drug should be coded